Raloxifene Provides an Alternative for Osteoporosis Prevention

Abbott TA Lawrence BJ Wallach S . Osteoporosis: The need for comprehensive treatment guidelines. Clin Ther 1996;18:127–49.

Witt DM Lousberg TR . Controversies surrounding estrogen use in postmenopausal women. Ann Pharmacother 1997;31:745–55.

Ravnikar VA . Compliance with hormone therapy. Am J Obstet Gynecol 1987;156:1332–4.

Masahiko S Bryant HU Iverson P Helterbrand J Smietana F Bemis K Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats. J Pharmacol Exp Ther 1996;279:298–305.

Lane JM Riley EH Wirganowicz PZ . Osteoporosis: Diagnosis and treatment. J Bone Joint Surg 1996;78-A:618–32.

Gradishar WJ Jordan VC . Clinical potential of new antiestrogens. J Clin Oncol 1997;15:840–52.

Mullins PM Pugh MC Moore AO . Hormone replacement therapy. In: DiPiro J Talbert R Yee G Matzke G Wells B Posey L . Pharmacotherapy: a pathophysiologic approach. 3rd ed. Stamford, CT: Appleton & Lange, 1996:1635–46.

Carr BR Bradshaw KD . Disorders of the ovary and female reproductive tract. In: Fauci AS Braunwald E Isselbacher KJ Wilson JD Martin JB Kasper DL Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:2097–115.

Mishell DR . Estrogen replacement therapy: An overview. Am J Obstet Gynecol 1989;161:1825–6.

Horowitz M . Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 1993;260:625–6.

Female physiology before pregnancy, and the female hormones. In: Guyton AC . Textbook of medical physiology. 7th ed. Philadelphia: WB Saunders Co., 1986:968–81.

Laya MB Larson EB Taplin SH White E . Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996;88:643–9.

Gambrell RD Massey FM Castaneda TA Ugenas AJ Ricci CA . Reduced incidence of endometrial cancer among postmenopausal women treated with progestens. J Am Geriatr Soc 1979;27:389–94.

Black LJ Sato M Rowley ER Magee DE Bekele A Williams DC Raloxifene (LY139481HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 1994;93:63–9.

Somjen D Waisman A Kaye AM . Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo. J Steroid Biochem Mol Biol 1996;59:389–96.

Draper MW Flowers DE Huster WJ Neild JA Harper KD Arnaud C . A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res 1996;11:835–42.

Delmas PD Bjarnason NH Mitlak BH Ravoux A Shah AS Huster WJ Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641–7.

Burton TM . Lilly osteoporosis treatment shows promise. Wall Street J 1997 Jun 6; sect. A:6 (col. 1).

Package insert. Evista (raloxifene). Indianapolis, IN: Eli Lilly and Co., December 1997.

Patel S . Current and potential future drug treatments for osteoporosis. Ann Rheum Dis 1996;55:700–14.

Package insert. Fosamax (alendromate). West Point, PA: Merck & Co., Inc., September 1995.

Lindley C . Breast cancer. In: DiPiro J Talbert R Yee G Matzke G Wells B Posey L . Pharmacotherapy: a pathophysiological approach. 3rd ed. Stamford, CT: Appleton & Lange, 1996:2467–97.

Dupont WD Page DL . Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67–72.

The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199–208.

McEvoy GK , ed. Estrogens. In: AHFS drug information. 39th ed. Bethesda, MD: American Society of Health-System Pharmacists, Inc., 1997:2395.

Kawas C Resnick S Morrison A Brookmeyer R Corrada M Zonderman A A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore longitudinal study of aging. Neurology 1997;48:1517–21.

Tang M Jacobs D Stern Y Marder K Schofield P Gurland B Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429–32.